This week, we chat with Senior Editor Andrew Tarantola about Neuralink, Elon Musk’s brain computer interface (BCI) company. The FDA reportedly denied approval for human trials last week—Andy explains why that happened, as well as what BCIs could mean for humans in the future. Also, Cherlynn dives into the accessibility news from Microsoft’s Ability Summit.
Listen below or subscribe on your podcast app of choice. If you’ve got suggestions or topics you’d like covered on the show, be sure to email us or drop a note in the comments! And be sure to check out our other podcasts, the Morning After and Engadget News!
Subscribe!
Topics
-
What’s going on with Neuralink and BCI tech? – 2:05
-
Elon Musk goes after disabled Twitter employee, quickly apologizes – 19:52
-
Microsoft touts new accessibility tech at 2023 Ability Summit – 28:32
-
Sonos’ Era 300 speaker finally has spatial audio – 35:04
-
What we think of the Yellow iPhone and a few other colorful gadgets announced this week – 45:25
-
Working On – 51:49
-
Around Engadget: the reMarkable Folio is a very pretty e-paper keyboard – 54:28
-
Pop culture picks – 56:29
Livestream
Credits
Hosts: Cherlynn Low and Devindra Hardawar
Guest (Audio): Andrew Tarantola
Producer: Ben Ellman
Music: Dale North and Terrence O’Brien
Livestream producers: Julio Barrientos
Graphic artists: Luke Brooks
This article originally appeared on Engadget at https://www.engadget.com/engadget-podcast-elon-musk-neuralink-human-trials-denied-133016676.html?src=rss
Brought to you by USA Today Read the rest of the article here.